Your research can change the world
More on impact ›
Gene Editing for the treatment of inherited and acquired blood disorders is a promising new approach which has the potential to provide lifelong correction of many debilitating diseases.
This section of Frontiers in Genome Editing is focused on providing a platform for the publication of improvements in existing gene editing methods and for initial publication of novel gene editing methods for the treatment of blood disorders. Review articles will also be published; these reviews will play an important role in integrating the field, providing novel perspectives, and serving as educational materials for graduate and professional students, basic and physician scientists and physicians practicing in large and small communities world-wide.
A small sample of blood disorders, for which gene editing strategies will be published, include:
The ultimate goal is to provide a forum for the publication of gene editing approaches for blood disorders as these methods progress from basic science to clinical medicine.
Indexed in: CLOCKSS, CrossRef, DOAJ, Google Scholar, OpenAIRE, PubMed Central (PMC)
Genome Editing in Blood Disorders welcomes submissions of the following article types: Brief Research Report, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective and Review.
All manuscripts must be submitted directly to the section Genome Editing in Blood Disorders, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com